QA: Enveric Biosciences Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000890821_2020_Enveric_Biosciences_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0000890821', 'EntityCommonStockSharesOutstanding': 7491544, 'Assets': 4096891, 'AssetsCurrent': 2279170, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 1817721, 'Liabilities': 681250, 'LiabilitiesAndStockholdersEquity': 4096891, 'LiabilitiesCurrent': 0, 'LiabilitiesNoncurrent': 0, 'NetIncome': -6864676, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 681250, 'remainder_LiabilitiesAndStockholdersEquity': 3415641, 'remainder_NetIncome': -4369958, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}

Graph

Absolute values for 0000890821, Enveric Biosciences Inc

  xvar xval
0 AssetsCurrent 7,599,154
1 IntangibleAssetsNetIncludingGoodwill 17,313,991
2 PropertyPlantAndEquipmentNet 83,128
3 remainder_Assets 8,879
4 LiabilitiesCurrent 14,383,605
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 31,978,191
8 SellingGeneralAndAdministrativeExpense 11,815,659
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 7,278,879
11 remainder_Revenues 40,211,296
12 remainder_NetIncome -3,396,007
13 remainder_ComprehensiveNetIncome -461,050
  yvar yval
0 Assets 25,005,152
1 Liabilities 14,383,605
2 Expenses 51,072,729
3 Revenues 40,211,296
4 StockholdersEquity 10,621,547
5 NetIncome -14,257,440
6 ComprehensiveNetIncome -14,487,965
7 BaseVar 67,264,920
8 EconomicCapitalRatiobeforeLimitedLiability 0.440
9 EconomicCapitalRatio 1.83

Edgar->Model Mapping

Feature Distribution

Change over Time